ALL | JIA | p | |
---|---|---|---|
N | 49 | 98 | |
Age, y (median [interquartile range]) | 7.3 [3.6–12.4] | 7.6 [3.1–12.4] | NS** |
Sex ratio, males per female | 1.9 | 0.7 | < 0.01* |
Time to diagnosis, days (median [interquartile range]) | 57 [38;90] | 121 [69;266] | < 0.001** |
Pain location, n (%) | |||
Joint pain | 40 (82) | 98 (100) | NS* |
Non-articular pain | 18 (37) | 7 (7) | < 0.001* |
Initial presentation, n (%) | < 0.05* | ||
Diffuse | 42 (86) | 68 (69) | |
Localized | 7 (14) | 30 (31) | |
Symptoms at diagnosis, n (%) | |||
Fever | 30 (61) | 12 (12) | < 0.001* |
General symptoms | |||
Asthenia | 34 (69) | 7 (7) | < 0.001* |
Anorexia | 12 (24) | 4 (4) | < 0.001* |
Weight loss | 10 (20) | 4 (4) | < 0.01*** |
Clinical manifestations at diagnosis, n (%) | |||
Arthritis | 1 (2) | 80 (82) | < 0.001* |
Hepatomegaly, splenomegaly or lymphadenopathy | 37 (76) | 2 (2) | < 0.001* |
Hepatomegaly | 23 (47) | 1 (1) | < 0.001* |
Splenomegaly | 15 (31) | 1 (1) | < 0.001* |
Lymphadenopathy | 28 (57) | 1 (1) | < 0.001* |
Anemia signs | 25 (51) | 1 (1) | < 0.001* |
Thrombocytopenia signs | 10 (20) | 0 (0) | < 0.001*** |
Neurological disorders | 8 (16) | 2 (2) | NS*** |
Dermatological signs | 1 (2) | 7 (7) | NS*** |